ONCY
Oncolytics Biotech·NASDAQ
--
--(--)
--
--(--)
ONCY fundamentals
Oncolytics Biotech (ONCY) released its earnings on Nov 12, 2025: revenue was 0 (YoY 0.00%), met estimates; EPS was -0.0999 (YoY -16.03%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.0999
-16.03%
Report date
Nov 12, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Oncolytics Biotech (ONCY) key financial stats and ratios, covering profitability, financial health, and leverage.
Oncolytics Biotech (ONCY)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Oncolytics Biotech (ONCY)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Oncolytics Biotech (ONCY)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Oncolytics Biotech (ONCY) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Oncolytics Biotech (ONCY) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Oncolytics Biotech's gross profit margin?What guidance did Oncolytics Biotech's management provide for the next earnings period?What factors drove the changes in Oncolytics Biotech's revenue and profit?What were the key takeaways from Oncolytics Biotech’s earnings call?What is the market's earnings forecast for Oncolytics Biotech next quarter?What is the revenue and EPS growth rate for Oncolytics Biotech year over year?What does Oncolytics Biotech do and what are its main business segments?What were the key takeaways from Oncolytics Biotech's earnings call?
